From Wikipedia, the free encyclopedia
Malan syndrome
Other namesMalan overgrowth syndrome, MALNS, Sotos-like syndrome, Sotos syndrome 2
Specialty Medical genetics
Symptoms Intellectual disability, overgrowth, Marfanoid habitus, visual problems
Usual onsetPresent at birth
Causes NFIX mutation
Diagnostic methodMolecular genetic testing
Differential diagnosis Marfan syndrome, Sotos syndrome, Weaver syndrome
ManagementBased on symptoms
Frequency80 reported cases [1]
Named after Valérie Malan

Malan syndrome (MALNS) is a rare overgrowth syndrome caused by autosomal dominant mutations in the NFIX gene. [1] The syndrome is characterized by overgrowth, craniofacial dysmorphia, intellectual disability, and behavioral issues. It was formerly diagnosed as Sotos syndrome 2. [2] [3]

Signs and symptoms

Malan syndrome is defined by initial overgrowth and mild-to-severe intellectual disability. Almost all individuals with Malan syndrome display above-average height, weight, and head circumference in early life, but only one-third of adults with Malan syndrome are >2 standard deviations above the mean. Most individuals display advanced bone age. Hypotonia and seizures may be observed.

All individuals display some degree of global developmental delay and intellectual disability which typically ranges from moderate to severe, though mild cases have been observed. Cognitive function, adaptive function, and language skills are impaired. [4] Anxiety and noise hypersensitivity are frequently reported. Autism spectrum features are observed in 31% of individuals. [2]

The facial gestalt of Malan syndrome includes dolichocephaly, a long or triangular face, prominent forehead, depressed nasal bridge, deep-set eyes, downslanting palpebral fissures, short nose with anteverted nares, long philtrum, everted lower lip, and prominent chin. Marfanoid features are extremely common, including scoliosis, hyper kyphosis or hyper lordosis, pectus excavatum or carinatum, slender habitus, and long hands. [3]

Ophthalmological features are common in Malan syndrome and can be used to distinguish it from Sotos syndrome. Vision impairments may include strabismus, myopia, hypermetropia, astigmatism, and nystagmus. Blue sclerae are often observed. [3]

Cause

Malan syndrome is caused by autosomal dominant mutations in the NFIX gene. Both variants and deletions have been reported. In some cases, the deletion also affects CACNA1A, which is associated with episodic ataxia type 2 or familial hemiplegic migraine. [5] Nearly all cases are caused by de novo mutations, though familial cases have been observed due to gonadal or parental mosaicism. [3]

Management

Individuals with Malan syndrome should receive comprehensive evaluation of all major body systems at diagnosis. Height, weight, head circumference, BMI, and food intake should be evaluated regularly. Orthopedic and visual evaluations are recommended annually until puberty. Risk of pathologic bone fracture is increased in Malan syndrome; bone integrity can be assessed via DXA. Neurological features such as epilepsy and vegetative symptoms should receive standard treatment. Neuropsychiatric and behavioral issues should be evaluated at diagnosis and managed as appropriate. [3]

See also

References

  1. ^ a b "Malan overgrowth syndrome". Orphanet. December 2020. Retrieved 2024-01-11.
  2. ^ a b Priolo M, Schanze D, Tatton-Brown K, Mulder PA, Tenorio J, Kooblall K; et al. (2018). "Further delineation of Malan syndrome". Hum Mutat. 39 (9): 1226–1237. doi: 10.1002/humu.23563. PMC  6175110. PMID  29897170.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)
  3. ^ a b c d e Macchiaiolo M, Panfili FM, Vecchio D, Gonfiantini MV, Cortellessa F, Caciolo C; et al. (2022). "A deep phenotyping experience: up to date in management and diagnosis of Malan syndrome in a single center surveillance report". Orphanet J Rare Dis. 17 (1): 235. doi: 10.1186/s13023-022-02384-9. PMC  9206304. PMID  35717370.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)
  4. ^ Alfieri P, Macchiaiolo M, Collotta M, Montanaro FAM, Caciolo C, Cumbo F; et al. (2022). "Characterization of Cognitive, Language and Adaptive Profiles of Children and Adolescents with Malan Syndrome". J Clin Med. 11 (14): 4078. doi: 10.3390/jcm11144078. PMC  9316998. PMID  35887841.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)
  5. ^ Klaassens M, Morrogh D, Rosser EM, Jaffer F, Vreeburg M, Bok LA; et al. (2015). "Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature". Eur J Hum Genet. 23 (5): 610–5. doi: 10.1038/ejhg.2014.162. PMC  4402637. PMID  25118028.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)
From Wikipedia, the free encyclopedia
Malan syndrome
Other namesMalan overgrowth syndrome, MALNS, Sotos-like syndrome, Sotos syndrome 2
Specialty Medical genetics
Symptoms Intellectual disability, overgrowth, Marfanoid habitus, visual problems
Usual onsetPresent at birth
Causes NFIX mutation
Diagnostic methodMolecular genetic testing
Differential diagnosis Marfan syndrome, Sotos syndrome, Weaver syndrome
ManagementBased on symptoms
Frequency80 reported cases [1]
Named after Valérie Malan

Malan syndrome (MALNS) is a rare overgrowth syndrome caused by autosomal dominant mutations in the NFIX gene. [1] The syndrome is characterized by overgrowth, craniofacial dysmorphia, intellectual disability, and behavioral issues. It was formerly diagnosed as Sotos syndrome 2. [2] [3]

Signs and symptoms

Malan syndrome is defined by initial overgrowth and mild-to-severe intellectual disability. Almost all individuals with Malan syndrome display above-average height, weight, and head circumference in early life, but only one-third of adults with Malan syndrome are >2 standard deviations above the mean. Most individuals display advanced bone age. Hypotonia and seizures may be observed.

All individuals display some degree of global developmental delay and intellectual disability which typically ranges from moderate to severe, though mild cases have been observed. Cognitive function, adaptive function, and language skills are impaired. [4] Anxiety and noise hypersensitivity are frequently reported. Autism spectrum features are observed in 31% of individuals. [2]

The facial gestalt of Malan syndrome includes dolichocephaly, a long or triangular face, prominent forehead, depressed nasal bridge, deep-set eyes, downslanting palpebral fissures, short nose with anteverted nares, long philtrum, everted lower lip, and prominent chin. Marfanoid features are extremely common, including scoliosis, hyper kyphosis or hyper lordosis, pectus excavatum or carinatum, slender habitus, and long hands. [3]

Ophthalmological features are common in Malan syndrome and can be used to distinguish it from Sotos syndrome. Vision impairments may include strabismus, myopia, hypermetropia, astigmatism, and nystagmus. Blue sclerae are often observed. [3]

Cause

Malan syndrome is caused by autosomal dominant mutations in the NFIX gene. Both variants and deletions have been reported. In some cases, the deletion also affects CACNA1A, which is associated with episodic ataxia type 2 or familial hemiplegic migraine. [5] Nearly all cases are caused by de novo mutations, though familial cases have been observed due to gonadal or parental mosaicism. [3]

Management

Individuals with Malan syndrome should receive comprehensive evaluation of all major body systems at diagnosis. Height, weight, head circumference, BMI, and food intake should be evaluated regularly. Orthopedic and visual evaluations are recommended annually until puberty. Risk of pathologic bone fracture is increased in Malan syndrome; bone integrity can be assessed via DXA. Neurological features such as epilepsy and vegetative symptoms should receive standard treatment. Neuropsychiatric and behavioral issues should be evaluated at diagnosis and managed as appropriate. [3]

See also

References

  1. ^ a b "Malan overgrowth syndrome". Orphanet. December 2020. Retrieved 2024-01-11.
  2. ^ a b Priolo M, Schanze D, Tatton-Brown K, Mulder PA, Tenorio J, Kooblall K; et al. (2018). "Further delineation of Malan syndrome". Hum Mutat. 39 (9): 1226–1237. doi: 10.1002/humu.23563. PMC  6175110. PMID  29897170.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)
  3. ^ a b c d e Macchiaiolo M, Panfili FM, Vecchio D, Gonfiantini MV, Cortellessa F, Caciolo C; et al. (2022). "A deep phenotyping experience: up to date in management and diagnosis of Malan syndrome in a single center surveillance report". Orphanet J Rare Dis. 17 (1): 235. doi: 10.1186/s13023-022-02384-9. PMC  9206304. PMID  35717370.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)
  4. ^ Alfieri P, Macchiaiolo M, Collotta M, Montanaro FAM, Caciolo C, Cumbo F; et al. (2022). "Characterization of Cognitive, Language and Adaptive Profiles of Children and Adolescents with Malan Syndrome". J Clin Med. 11 (14): 4078. doi: 10.3390/jcm11144078. PMC  9316998. PMID  35887841.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)
  5. ^ Klaassens M, Morrogh D, Rosser EM, Jaffer F, Vreeburg M, Bok LA; et al. (2015). "Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature". Eur J Hum Genet. 23 (5): 610–5. doi: 10.1038/ejhg.2014.162. PMC  4402637. PMID  25118028.{{ cite journal}}: CS1 maint: multiple names: authors list ( link)

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook